029-83533393
   info@TaiBSbio.com
 
组织芯片,组织微阵列
 
UBD802膀胱癌及膀胱组织组合芯片,附TNM和临床分期,78例/80点
点 数80例 数78
行 数8列 数10
点直径(mm)1.5厚度(µm)5.0
组织阵列类型石蜡包埋种 属人类
QA/QCH&E and IHC confirmed
ApplicationsRoutine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page.
Notes1.Please keep the slides at 4 ℃ after receiving, and make experiment within 3 months will be better.

2.Bake the slides for 30 minutes at 60℃ before the experiment;

3.Please choose a gentle repair method to avoid tissue detachment.

产品名:UBD802
 
膀胱癌及膀胱组织组合微阵列芯片,包含尿路上皮癌60例,边缘和癌旁膀胱组织各10例(其中2例与癌匹配),一块一点
 
 
询价  Tel: 029-83533393
 
下载说明书
 
 
Legend:
Bla
-Bladder
 
AT (*)
 
Malignant (I)
 
Malignant (II)
 
Malignant (IIIA)
 
Malignant (IIIB)
 
NAT (*)
TISSUE  ARRAYS UBD802
1
2
3
4
5
6
7
8
9
10
A
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
B
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
C
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
D
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
E
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
F
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
G
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
H
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
 
PosNoAgeSexOrgan_Anatomic_SitePathology_diagnosisGradeTNMStageTypeTumor SizeisBackUp
A1145FBladderLow-grade urothelial carcinoma*T1N0M0IMalignant3*2*1.5N
A2242MBladderLow-grade urothelial carcinoma*T1N0M0IMalignant4*3*3N
A3350MBladderLow-grade urothelial carcinoma*T1N0M0IMalignant5*3*2N
A4425FBladderLow-grade urothelial carcinoma*T2N0M0IIMalignant13*10*8N
A5571MBladderLow-grade urothelial carcinoma*T2bN0M0IIMalignant4.5*3*2N
A6656FBladderLow-grade urothelial carcinoma*T2N0M0IIMalignant6*5*0.5N
A7766MBladderLow-grade urothelial carcinoma*T2N0M0IIMalignant3*3*2N
A8855MBladderLow-grade urothelial carcinoma*T3bN0M0IIIAMalignant*N
A9972MBladderLow-grade urothelial carcinoma*T3N0M0IIIAMalignant4*3*2N
A101058MBladderLow-grade urothelial carcinoma*T1N0M0IMalignant8*7*5N
B11170MBladderLow-grade urothelial carcinoma*T1N0M0IMalignant5*4*4N
B21261MBladderLow-grade urothelial carcinoma*T2N0M0IIMalignant*N
B31370MBladderLow-grade urothelial carcinoma*T2N0M0IIMalignant10*7*5N
B41451MBladderLow-grade urothelial carcinoma*T1N0M0IMalignant6*4*2N
B51582FBladderLow-grade urothelial carcinoma*T1N0M0IMalignant3*3*2.5N
B61679FBladderLow-grade urothelial carcinoma*T2N0M0IIMalignant10*5*1.5N
B71765MBladderLow-grade urothelial carcinoma*T2N0M0IIMalignant*N
B81880FBladderLow-grade urothelial carcinoma*T1N0M0IMalignant*N
B91944FBladderLow-grade urothelial carcinoma*T2aN0M0IIMalignant*N
B102065MBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant*N
C12145FBladderHigh grade urothelial carcinoma*T1N0M0IMalignant*N
C22278FBladderHigh grade urothelial carcinoma*T1N0M0IMalignant7*5*2N
C32365MBladderHigh grade urothelial carcinoma*T1N0M0IMalignant3*2*1N
C42477FBladderHigh grade urothelial carcinoma*T1N0M0IMalignant2*1.5*1N
C52561MBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant*N
C62642MBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant5*5*4N
C72770FBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant3*2*2N
C82867MBladderHigh grade urothelial carcinoma*T2aN0M0IIMalignant4*3*3N
C92970MBladderHigh grade urothelial carcinoma*T2aN0M0IIMalignant6*5*3N
C103057FBladderHigh grade urothelial carcinoma*T3N0M0IIIAMalignant6*4*4N
D13167MBladderHigh grade urothelial carcinoma*T3N0M0IIIAMalignant7*4*3N
D23267MBladderHigh grade urothelial carcinoma*T3N0M0IIIAMalignant*N
D33365FBladderHigh grade urothelial carcinoma*T3aM0N0IIIAMalignant4*3*2N
D43471MBladderHigh grade urothelial carcinoma*T3bN0M0IIIAMalignant8*7N
D53545MBladderHigh grade urothelial carcinoma*T3bN0M0IIIAMalignant*N
D63668MBladderHigh grade urothelial carcinoma*T3bN0M0IIIAMalignant*N
D73752MBladderHigh grade urothelial carcinoma*T4aN0M0IIIBMalignant*N
D83878MBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant5*5*2N
D93980MBladderHigh grade urothelial carcinoma*T2bN0M0IIMalignant*N
D104036MBladderHigh grade urothelial carcinoma*T2bN0M0IIMalignant*N
E14172MBladderHigh grade urothelial carcinoma*T3aN0M0IIIAMalignant12*12*5N
E24256MBladderHigh grade urothelial carcinoma with necrosis*T3N0M0IIIAMalignant*N
E34360FBladderHigh grade urothelial carcinoma (sparse)*T3N0M0IIIAMalignant5.0N
E44443FBladderHigh grade urothelial carcinoma with necrosis*T2N0M0IIMalignant*N
E54550FBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant3*2*2N
E64653MBladderHigh grade urothelial carcinoma*T3bN0M0IIIAMalignant11*8*4N
E74770MBladderHigh grade urothelial carcinoma*T1N0M0IMalignant5*3*2N
E84845FBladderHigh grade urothelial carcinoma*T3N0M0IIIAMalignant10*7*7N
E94956MBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant3*2*1N
E105042MBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant3*2*1N
F15170MBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant5*2.5*2.5N
F25250FBladderHigh grade urothelial carcinoma*T1N0M0IMalignant7*4*3N
F35370MBladderHigh grade urothelial carcinoma*T1N0M0IMalignant3*3*2N
F45453MBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant*N
F55561MBladderHigh grade urothelial carcinoma*T2aN0M0IIMalignant4*3*2.5N
F65636FBladderHigh grade urothelial carcinoma*T1N0M0IMalignant5.0N
F75772MBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant*N
F85863MBladderHigh grade urothelial carcinoma*T2aN0M0IIMalignant*N
F95980MBladderHigh grade urothelial carcinoma*T2bN0M0IIMalignant*N
F106072MBladderHigh grade urothelial carcinoma*T2bN0M0IIMalignant1.5*1*0.6N
G16151MBladderAdjacent normal bladder tissue***NAT*N
G26240FBladderAdjacent normal bladder tissue***NAT*N
G36353MBladderAdjacent normal bladder tissue with squamous metaplasia of No.46***NAT*N
G46470FBladderAdjacent normal bladder tissue***NAT*N
G56551MBladderAdjacent normal bladder tissue***NAT*N
G66633MBladderAdjacent normal bladder tissue***NAT*N
G76753MBladderAdjacent normal bladder tissue***NAT*N
G86837FBladderAdjacent normal bladder tissue***NAT*N
G96951MBladderAdjacent normal bladder tissue***NAT*N
G107050FBladderAdjacent normal bladder tissue***NAT*N
H17152MBladderCancer adjacent bladder tissue***AT*N
H27249FBladderCancer adjacent bladder tissue***AT*N
H37358FBladderCancer adjacent bladder tissue***AT*N
H47471MBladderCancer adjacent bladder tissue of No.34***AT*N
H57563MBladderCancer adjacent bladder tissue***AT*N
H67677MBladderCancer adjacent bladder tissue***AT*N
H77755MBladderCancer adjacent bladder tissue***AT*N
H87854MBladderCancer adjacent bladder tissue***AT*N
H97972MBladderCancer adjacent bladder tissue***AT*N
H108060MBladderCancer adjacent bladder tissue***AT*N
Tissue Marker
 
 
西安泰博斯生物科技有限公司

 
联系我们
地址:陕西西安市灞桥区长乐东路2999号
电话:029-83533393, 17792711553,
电子邮箱:taibsbio@163.com
QQ:3144647811
微信号:13002913390
邮政编码:710075
关于我们
西安泰博斯生物科技有限公司主要经营组织芯片的研发、销售,加工定制和与组织芯片有关的生物技术服务项目。公司目前拥有专业的病理医生和技术研发团队,并且具有庞大的组织标本库。样本库中组织微阵列种类多,病理类型齐全,同时根据客户需求情况进行制作加工新的组织微阵列,尽量满足每一个客户的需求。公司一直秉承着“认真、严谨、负责”的工作态度,致力于为广大客户提供质量好的产品和优质的服务。

更多详情